United Therapeutics reported $7.7 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 6.94 6.63 May/06
FY2025Q4 Dec/2025 7.70 7.07 6.19 Feb/25
FY2025Q3 Sep/2025 7.16 7.43 6.39 Oct/29
FY2025Q2 Jun/2025 6.41 7.35 5.85 Jul/30
FY2025Q1 Mar/2025 6.63 6.53 6.17 Apr/30




Eps Change Date
Amarin USD 0.14 0.06 Dec/2025
Ardelyx USD 0 0 Dec/2025
Baxter International USD 0.44 0.25 Dec/2025
Bayer EUR 0.62 0.05 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Omeros USD -1.12 0.37 Jun/2024
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
United Therapeutics USD 7.7 0.54 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025